In order to complete the merger of Paratek Pharmaceuticals, Inc. (Paratek) with Radius Health, Inc. (Radius Health), Akin advised Pharmakon Advisors, LP and its affiliated funds on a fresh $100 million investment. Pharmakon’s investment replaces Paratek’s prior $50 million investment, which was fully reimbursed by the new funding. B-Flexion Life Sciences supports Paratek and Radius Health.